Publikationen
https://pubmed.ncbi.nlm.nih.gov
Selected publications
- Obermann W, Friedrich A, Madhugiri R, Klemm P, Mengel JP, Hain T, Pleschka S, Wendel HG, Hartmann RK, Schiffmann S, Ziebuhr J, Müller C*, Grünweller A*. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity. Viruses. 2022 Mar 3;14(3):519. doi: 10.3390/v14030519. PMID: 35336926; PMCID: PMC8950828.
- Pfafenrot C*, Schneider T*, Müller C*, Hung LH, Schreiner S, Ziebuhr J, Bindereif A. Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs. Nucleic Acids Res. 2021 Dec 2;49(21):12502-12516. doi: 10.1093/nar/gkab1096. PMID: 34850109; PMCID: PMC8643703.
- Shaban MS*, Müller C*, Mayr-Buro C*, Weiser H, Meier-Soelch J, Albert BV, Weber A, Linne U, Hain T, Babayev I, Karl N, Hofmann N, Becker S, Herold S, Schmitz ML, Ziebuhr J, Kracht M. Multi-level inhibition of coronavirus replication by chemical ER stress. Nat Commun. 2021 Sep 20;12(1):5536. doi: 10.1038/s41467-021-25551-1. PMID: 34545074; PMCID: PMC8452654.
- Müller C, Schulte FW, Lange-Grünweller K, Obermann W, Madhugiri R, Pleschka S, Ziebuhr J, Hartmann RK, Grünweller A. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses. Antiviral Res. 2018 Feb;150:123-129. doi: 10.1016/j.antiviral.2017.12.010. Epub 2017 Dec 16. PMID: 29258862; PMCID: PMC7113723.
- Müller C, Hardt M, Schwudke D, Neuman BW, Pleschka S, Ziebuhr J. Inhibition of Cytosolic Phospholipase A2α Impairs an Early Step of Coronavirus Replication in Cell Culture. J Virol. 2018 Jan 30;92(4):e01463-17. doi: 10.1128/JVI.01463-17. PMID: 29167338; PMCID: PMC5790932.